ArticleCirculation research2021
Novel Mechanisms of Exosome-Mediated Phagocytosis of Dead Cells in Injured Heart.
Erratum issuedOpen access · bronzeAbstract read
In one paragraph
Article in Circulation research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 38 papers.
0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 62 citations in OpenAlex.
- Review
- Engineering Extracellular Vesicles for Anti-Aging Therapy: Mechanisms, Applications, and Perspectives.Aging cell · 2026Review
- Nanotechnology for atherosclerotic plaque stabilisation: bridging innovation and clinical practice.EBioMedicine · 2026Review
- Efferocytosis in myocardial infarction: the regulatory core from inflammation resolution to cardiac repair.Frontiers in immunology · 2026Review
- Harnessing Natural Extracellular Vesicles to Combat Age-Related Diseases: From Aging Drivers to Therapeutic Opportunities.International journal of nanomedicine · 2026Review
- The Promise of Exosomes in Cardiac Repair: When 'Best Things Come in Small Packages'.Journal of cellular and molecular medicine · 2025Review
- Uncovering the bequeathing potential of apoptotic mesenchymal stem cells via small extracellular vesicles for its enhanced immunomodulatory and regenerative ability.Stem cell research & therapy · 2025Article
- Osteosarcoma Cell-Derived Migrasomes Promote Macrophage M2 Polarization to Aggravate Osteosarcoma Proliferation and Metastasis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Mesenchymal stem cells derived exosomes: a new era in cardiac regeneration.Stem cell research & therapy · 2025Review
- The Potential of Mesenchymal Stem Cell-Derived Exosomes in Cardiac Repair.International journal of molecular sciences · 2024Review
- The Role of Cardiac Macrophages in Inflammation and Fibrosis after Myocardial Ischemia-Reperfusion.Reviews in cardiovascular medicine · 2024Review
- Article
- Progress in extracellular vesicle homeostasis as it relates to cardiovascular diseases.Journal of physiology and biochemistry · 2024Review
- Tipifarnib Reduces Extracellular Vesicles and Protects From Heart Failure.Circulation research · 2024Article
- Fibroblast-Specific Depletion of Human Antigen R Alleviates Myocardial Fibrosis Induced by Cardiac Stress.JACC. Basic to translational science · 2024Article
- Roles of extracellular vesicles on macrophages in inflammatory bone diseases.Molecular and cellular biochemistry · 2024Review
- Extracellular vesicles containing MFGE8 from colorectal cancer facilitate macrophage efferocytosis.Cell communication and signaling : CCS · 2024Article
- Head-to-head comparison of relevant cell sources of small extracellular vesicles for cardiac repair: Superiority of embryonic stem cells.Journal of extracellular vesicles · 2024Article
- Mesenchymal stem cell-derived extracellular vesicles targeting irradiated intestine exert therapeutic effects.Theranostics · 2024Article
- Exosomes: Methods for Isolation and Characterization in Biological Samples.Methods in molecular biology (Clifton, N.J.) · 2024Review
Corrections and comments
- Erratum issued
Authors and funding
12 authors at 1 institution in 1 country.
Mallikarjun Patil *Department of Biomedical Engineering, Schools of Medicine and Engineering, University of Alabama at Birmingham.
Sherin Saheera *Department of Biomedical Engineering, Schools of Medicine and Engineering, University of Alabama at Birmingham.ORCID 0000-0002-1336-5872
Praveen K DubeyDepartment of Biomedical Engineering, Schools of Medicine and Engineering, University of Alabama at Birmingham.
Asher Kahn-KrellDepartment of Biomedical Engineering, Schools of Medicine and Engineering, University of Alabama at Birmingham.ORCID 0000-0001-7793-3130
Prem Kumar GovindappaDepartment of Biomedical Engineering, Schools of Medicine and Engineering, University of Alabama at Birmingham.ORCID 0000-0001-8069-234X
Sarojini SinghDepartment of Biomedical Engineering, Schools of Medicine and Engineering, University of Alabama at Birmingham.
Sultan TousifDepartment of Biomedical Engineering, Schools of Medicine and Engineering, University of Alabama at Birmingham.
Qinkun ZhangDepartment of Biomedical Engineering, Schools of Medicine and Engineering, University of Alabama at Birmingham.
Hind LalDepartment of Biomedical Engineering, Schools of Medicine and Engineering, University of Alabama at Birmingham.ORCID 0000-0001-8980-9874
Jianyi ZhangDepartment of Biomedical Engineering, Schools of Medicine and Engineering, University of Alabama at Birmingham.ORCID 0000-0002-3955-6554
Gangjian QinDepartment of Biomedical Engineering, Schools of Medicine and Engineering, University of Alabama at Birmingham.
Prasanna KrishnamurthyDepartment of Biomedical Engineering, Schools of Medicine and Engineering, University of Alabama at Birmingham.ORCID 0000-0002-4842-6364
University of Alabama at Birmingham · US
Funding
Signaling Mechanisms Governing Myocardial Fibrosis in Diseased HeartR01HL133290 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Hind Lal · 2017 to 2026
$3.6MProject-002R01HL143074 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Hind Lal · 2019 to 2026
$3.4MMesenchymal Stem Cell Exosome in Efferocytosis of Apoptotic Cardiomyocytes and Repair after Myocardial IschemiaR01HL138023 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KRISHNAMURTHY, PRASANNA, ZHANG, JIANYI · 2018 to 2021
$2.6MmicroRNA mediation of Endothelial Progenitor Cell function in Myocardial IchemiaR01HL116729 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KRISHNAMURTHY, PRASANNA · 2013 to 2017
$1.9MDevelopment and Functional Assessment of Cardiovascular Tissue Engineering Therapy (CVTE) T32 Training GrantT32EB023872 · NIBIB · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ROGERS, JACK M, ZHANG, JIANYI · 2018 to 2022
$753kNHLBI NIH HHS R01 HL116729NHLBI NIH HHS R01 HL133290NHLBI NIH HHS R01 HL138023NHLBI NIH HHS R01 HL143074NIBIB NIH HHS T32 EB023872
Abstract
[Figure: see text].
Indexed as
ApoptosisPhagocytosisAnimalsAntigens, SurfaceCells, CulturedExosomesIntegrinsMacrophagesMaleMiceMice, Inbred C57BLMilk ProteinsMyocardial IschemiaMyocytes, CardiacRAW 264.7 CellsAntigens, SurfaceIntegrinsMfge8 protein, mouseMilk Proteinsexosomesmesenchymal stem cellsopsonin proteinsphosphatidylserinesRNA, small interfering
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.